NDARC welcomes Australian Government’s drug and alcohol funding commitment

Image - NDARC welcomes Australian Government’s drug and alcohol funding commitment
Date Published:
27 Feb 2019
Contact person:
Marion Downey
Phone:
(02) 9385 0180

The National Drug and Alcohol Research Centre (NDARC) at UNSW Sydney has welcomed today’s announcement by the Australian Government of $268 million in funding to support drug and alcohol research and treatment in Australia.

Today’s announcement includes $24 million over three years for the four national research centres: NDARC, National Centre for Education and Training on Addiction (NCETA), Centre for Youth Substance Abuse Research (CYSAR) and National Drug Research Institute (NDRI).

NDARC’s Director, Professor Michael Farrell said the research funding would provide certainty going forward over the next three years for all four national research centres.

“NDARC has been strongly supported by the Australian Government Department of Health since its inception at UNSW Sydney in 1987,” said Professor Farrell. 

“The original aim was to develop research and research infrastructure in Australia.

“NDARC and the other national centres NDRI, NCETA and CYSAR, as well as numerous other collaborators in Australia and internationally, continue to direct their research effort to increasing knowledge about the extent of alcohol and other drug related harms and the effectiveness of prevention, treatment and other intervention responses to these harms.

“Today’s announcement supports our continuing effort to develop the infrastructure and capacity for research, treatment, training and policy development in the drug and alcohol field which affects hundreds of thousands of Australians and their families in the health, social and economic spheres.”

Professor Farrell also welcomed the announcement of $7.2 million to pilot a take home naloxone (THN) program in Australia. Naloxone is a drug that can reverse the effects of opioid overdose.

“The number of opioid deaths in Australia have been increasing, with the majority of those attributable to pharmaceutical opioids,” said Professor Farrell.

“The use of take-home naxolone is one of a number of strategies that can reduce those deaths.”

The full announcement from Minister Hunt’s is available here.